IMMUCOTHEL® / VACMUNE® (KLH)
Carrier protein/adjuvant for investigational vaccines (Cancer, Infectious Disease)
Key Facts
About BioSyn
BioSyn Corporation is a privately held biopharmaceutical company with a unique focus on hemocyanin and selenium-based therapeutics. Founded in 1980 and headquartered in Carlsbad, California, the company has established itself as the global leader in manufacturing high-purity KLH, a critical carrier protein and adjuvant used in over 100 clinical trials worldwide. Its vertically integrated operations include a dedicated GMP facility with specialized aquaria for the sustainable, non-lethal harvesting of Giant Keyhole Limpets. While generating revenue from research and clinical-grade product sales, BioSyn's pipeline includes its KLH products in various investigational uses and its Selenase® product for conditions like sepsis.
View full company profile